Dave Hughes, CEO and co-founder of Novosound, said:
“At its core, Novosound is an ultrasound sensors company with a patented manufacturing method…our main play is an ultrasound sensing platform that enables our customers to achieve market edge, safety and efficiency by getting ultrasound data from previously untapped places.”
It has been a great first half to 2022, including new contract wins and further patents on our technology. To round off the end of June, Dave was featured in Scotland on Sunday as part of their two page Big Interview.
The article provides an overview of Novosound’s journey so far, the impact of the last 2 years, and where the business is going next. Dave also discusses the origin of our products and their names, as well as why moving into the healthcare market brings Novosound full circle.
“We effectively become our client’s centre of excellence for ultrasound, developing solutions for them built upon our thin film, or printed technology and providing them with the data and insight they require to solve their problems.”
You can read the full article here.